Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First chemically synthesized ribozyme heading for human studies for cancer

Sep. 23, 1998

New MMP inhibitors in early development at Ono

Sep. 23, 1998

Kyowa Hakko studies DC-107 derivatives as antitumor/antibacterial agents

Sep. 23, 1998

Cephalon presents CEP-701 at German cancer meeting

Sep. 22, 1998

Takeda describes preparation and use of inhibitors of steroid C17-20 lyase

Sep. 22, 1998

Procyon receives U.S. patent for the use of ANAs in the treatment of cancer

Sep. 22, 1998

Sugen initiates two new trials with lead compound

Sep. 22, 1998

Gene transfer may be an effective strategy for treatment of AIDS-related Kaposi's sarcoma

Sep. 22, 1998

Spotlight on angiogenesis inhibitors in clinical testing

Sep. 22, 1998

Pacific Pharmaceuticals initiates NCI-sponsored trial at Duke University Medical Center

Sep. 21, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...